Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
A Safety and Efficacy Study of Hospitalized Patients with Community-Acquired Pneumonia and Sepsis Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for proven healthcare advice, travels to or treatment by using a genuine medical doctor. We are not physicians. Always confer with your doctor on A Safety and Efficacy Study of Hospitalized Patients with Community-Acquired Pneumonia and Sepsis conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. A Safety and Efficacy Study of Hospitalized Patients with Community-Acquired Pneumonia and Sepsis Clinical research trials and A Safety and Efficacy Study of Hospitalized Patients with Community-Acquired Pneumonia and Sepsis healthcare trials take place in many of cities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectiveness of new drugs. The function of the studies / undertakings is to answer specific human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector companies to find treatments for all forms of conditions, including A Safety and Efficacy Study of Hospitalized Patients with Community-Acquired Pneumonia and Sepsis. A Safety and Efficacy Study of Hospitalized Patients with Community-Acquired Pneumonia and Sepsis Clinical Trials and other clinical trials allow for volunteers to access medical treatment alternatives before they are available to the masses. Many times the test subjects undergo treatment for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a A Safety and Efficacy Study of Hospitalized Patients with Community-Acquired Pneumonia and Sepsis clinical trial. Test subjects oftentimes recieve the best healthcare possible for their A Safety and Efficacy Study of Hospitalized Patients with Community-Acquired Pneumonia and Sepsis condition. Hazards are a reality, nonetheless, and might include additional or frequent doctor trips, healthcare hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.

Home > "A" Clinical Trials Conditions > A Safety and Efficacy Study of Hospitalized Patients with Community-Acquired Pneumonia and Sepsis

A Safety and Efficacy Study of Hospitalized Patients with Community-Acquired Pneumonia and Sepsis



A Safety and Efficacy Study of Hospitalized Patients with Community-Acquired Pneumonia and Sepsis

For Condition: Pneumonia,Sepsis
Status: Completed
Sponsor(s): ICOS ,
Synopsis: The objective of this study is to demonstrate the safety and efficacy of IC14 in the treatment of hospitalized patients with community-acquired pneumonia and sepsis.
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Randomized, Double-Blind, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Current diagnosis of community-acquired pneumonia. - Evidence of systemic inflammatory response to infection. Exclusion Criteria: - Atypical or viral pneumonia based on clinical or epidemiologic suspicion by the investigator. - Presence of organ failure.
Total Enrollment: 

Location and Contact Information:

ICOS Corporation
Bothell,  Washington,  98021
United States
 


Additional Information:
Study ID Numbers:
  EPN01;  EPN01
Study Start Date: May 2002
Record last reviewed: January 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00042588

Other Pneumonia Studies:
1. Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation

2. Intravenous Tigecycline Versus Intravenous Levofloxacin To Treat Subjects Hospitalized With Community-Acquired Pneumonia

3. Intravenous azithromycin plus intravenous ceftriaxone followed by oral azithromycin with intravenous levofloxacin followed by oral levofloxacin for the treatment of moderate to severely ill hospitalized patients with community acquired pneumonia.

4. Tigecycline for the Treatment of Subjects with Selected Serious Infections Due to Resistant Gram-Negative Organisms

5. Arginine Treatment of Acute Chest Syndrome (Pneumonia) in Sickle Cell Disease Patients

Related Studies:

Other Pneumonia Clinical Trials
Other Washington Clinical Trials
Other Bothell Clinical Trials

A Safety and Efficacy Study of Hospitalized Patients with Community-Acquired Pneumonia and Sepsis

Modify your Search

  Other Pneumonia Clinical Trials
  Other Washington Clinical Trials
  Other Bothell Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103